The Latest in Rheumatology

Duloxetine added to usual care doesn’t improve hip, knee OA pain

January 6, 2022

Rheumatology achieves 95% fill rate in 2021 MSMP Match; pediatric subspecialty lags

January 3, 2022

Tofacitinib approved for new ankylosing spondylitis indication

December 16, 2021

Rheumatology

Upadacitinib (Rinvoq) gains psoriatic arthritis as second FDA-approved indication

December 15, 2021

Rheumatology

Alternative rheumatology practice models aim to avoid traditional limitations

December 14, 2021

Giant cell arteritis fast-track clinics pave way for greater ultrasound use in U.S.

December 7, 2021

Guselkumab’s efficacy, safety confirmed in patients with psoriatic arthritis and prior TNFi exposure

December 2, 2021

Validity of commercial serologic tests for dermatomyositis still questionable

November 24, 2021

Platelet-rich plasma injections show no benefit in knee OA in placebo-controlled trial

November 23, 2021

Rheumatology

Secukinumab beat placebo for sustained remission of giant cell arteritis after steroid taper

November 22, 2021

Rheumatology

Serious infection hospitalizations have declined in patients with PsA

November 19, 2021

Rheumatology

Low-dose rituximab may keep RA disease activity low in responders

November 19, 2021

Rheumatology

ADVOCATE: Avacopan shows renal benefits in ANCA vasculitis

November 17, 2021

Long-term glucocorticoids in RA linked to increased cardiovascular risk

November 17, 2021

Adding rituximab to belimumab offers no help for lupus

November 16, 2021

Rheumatology